AZN

Astrazeneca PLC

79.57 USD
-0.02 (-0.03%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Astrazeneca PLC stock is up 3.47% since 30 days ago. The next earnings date is Jul 25, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 42.31% of the previous 25 June’s closed higher than May. In the last 10 Unusual Options Trades, there were 7 CALLs, 3 PUTs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
04 Jun 13:47 16 Jan, 2026 65.00 CALL 40 327
04 Jun 17:55 07 Jun, 2024 80.00 CALL 510 133
05 Jun 17:58 17 Jan, 2025 90.00 CALL 100 1498
06 Jun 13:40 19 Jul, 2024 67.50 CALL 20 753
11 Jun 13:31 16 Jan, 2026 77.50 PUT 45 641
11 Jun 14:40 18 Oct, 2024 85.00 CALL 198 1090
12 Jun 13:30 16 Jan, 2026 87.50 PUT 49 0
12 Jun 17:32 17 Jan, 2025 70.00 CALL 38 1100
13 Jun 14:08 16 Jan, 2026 65.00 CALL 25 368
14 Jun 18:09 19 Jul, 2024 77.50 PUT 261 2871

About Astrazeneca PLC

AstraZeneca PLC focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex. The company serves primary care and specialty care physicians through distributors in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia.

  • Argus Research
    Thu May 30, 14:00
    buy
    confirm
  • Goldman Sachs
    Thu May 30, 06:44
    buy
    initial